Brain fatty acid synthase activates PPAR? to maintain energy homeostasis

Journal of Clinical Investigation

Volumn 117, Issue 9, 2007, Pages 2539-2552

  Chakravarthy, Manu V ^a   Zhu, Yimin ^a   López, Miguel ^b   Yin, Li ^a   Wozniak, David F ^a   Coleman, Trey ^a   Hu, Zhiyuan ^c   Wolfgang, Michael ^c   Vidal Puig, Antonio ^b   Lane, M Daniel ^c   Semenkovich, Clay F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FATTY ACID SYNTHASE; MALONYL COENZYME A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY; FEMALE; GENE TARGETING; HOMEOSTASIS; LIPOGENESIS; MALE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ANIMALS; APPETITIVE BEHAVIOR; BODY WEIGHT; CELL DIFFERENTIATION; ENZYME ACTIVATION; FATTY ACID SYNTHETASE COMPLEX; FEMALE; HOMEOSTASIS; HORMONES; HYPOTHALAMIC DISEASES; INSULIN-SECRETING CELLS; MALE; MICE; MICE, KNOCKOUT; PPAR ALPHA; SIGNAL TRANSDUCTION;

EID: 34548860424     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI31183     Document Type: Article

References (52)

1. Morton, G.J., Cummings, D.E., Baskin, D.G., Barsh, G.S., and Schwartz, M.W. 2006. Central nervous system control of food intake and body weight. Nature. 443:289-295.
2. Seeley, R.J., and Woods, S.C. 2003. Monitoring of stored and available fuel by the CNS: implications for obesity. Nat. Rev. Neurosci. 4:901-909.
3. Adams, K.R., et al. 2006. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N. Engl. J. Med. 355:763-778.
4. Gelber, R.P., Kurth, T., Manson, J.E., Buring, J.E., and Gaziano, J.M. 2007. Body mass index and mortality in men: evaluating the shape of the association. Int. J. Obes. (Lond.). In press.
5. Bouchard, C. 2000. Inhibition of food intake by inhibitors of fatty acid synthase. N. Engl. J. Med. 343:1888-1890.
6. Hu, Z., Dai, Y., Prentki, M., Chohnan, S., and Lane, M.D. 2005. A role for hypothalamic malonyl-CoA in the control of food intake. J. Biol. Chem. 280:39681-39683.
7. Obici, S., Feng, Z., Arduini, A., Conti, R., and Rossetti, L. 2003. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat. Med. 9:756-761.
8. Semenkovich, C.F. Regulation of fatty acid synthase (FAS). 1997. Prog. Lipid Res. 36:43-53.
9. Loftus, T.M., et al. 2000. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science. 288:2379-2381.
10. Cha, S.H., Hu, Z., Chohnan, S., and Lane, M.D. 2005. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle Proc. Natl. Acad. Sci. U. S. A. 102:14557-14562.
11. Cha, S.H., Rodgers, J.T., Puigserver, P., Chohnan, S., and Lane, M.D. 2006. Hypothalamic malonyl-CoA triggers mitochondrial biogenesis and oxidative gene expression in skeletal muscle: role of PGC1alpha. Proc. Natl. Acad. Sci. U. S. A. 103:15410-15415.
12. Wortman, M.D., Clegg, D.J., D'Alessio, D., Woods, S.C., and Seeley, R.J. 2003. C75 inhibits food intake by increasing CNS glucose metabolism. Nat. Med. 9:483-485.
13. Woods, S.C., Lotter, E.C., McKay, L.D., and Porte, D., Jr. 1979. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature. 282:503-505.
14. Lin, X., et al. 2004. Dysregulation of insulin receptor substrate 2 in ? cells and brain causes obesity and diabetes. J. Clin. Invest. 114:908-916. doi:10.1172/JCI200422217.
15. Choudhury, A.I., et al. 2005. The role of insulin receptor substrate 2 in hypothalamic and β cell function. J. Clin. Invest. 115:940-950. doi:10.1172/JCI200524445.
16. Herrero, L., et al. 2005. Alteration of the malonyl-CoA/carnitine palmitoyltransferase I interaction in the beta cell impairs glucose-induced insulin secretion. Diabetes. 54:462-471.
17. Pocai, A., et al. 2006. Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J. Clin. Invest. 116:1081-1091. doi:10.1172/JCI26640.
18. Fukuda, H., Iritani, N., Sugimoto, T., and Ikeda, H. 1999. Transcriptional regulation of fatty acid synthase gene by insulin/glucose, polyunsaturated fatty acid and leptin in hepatocytes and adipocytes in normal and genetically obese rats. Eur. J. Biochem. 260:505-511.
19. Dudek, S.M., and Semenkovich, C.F. 1995. Essential amino acids regulate fatty acid synthase expression through an uncharged transfer RNA-dependent mechanism. J. Biol. Chem. 270:29323-29329.
20. Semenkovich, C.F., Coleman, T., and Goforth, R. 1993. Physiologic concentrations of glucose regulate fatty acid synthase activity in HepG2 cells by mediating fatty acid synthase mRNA stability. J. Biol. Chem. 268:6961-6970.
21. Shillabeer, G., et al. 1992. Fatty acid synthase and adipsin mRNA levels in obese and lean JCR:LA-cp rats: effect of diet. J. Lipid Res. 33:31-39.
22. Kovacs, P., et al. 2004. A novel missense substitution (Val1483Ile) in the fatty acid synthase gene (FAS) is associated with percentage of body fat and substrate oxidation rates in nondiabetic Pima Indians. Diabetes. 53:1915-1919.
23. Chirala, S.S., et al. 2003. Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero. Proc. Natl. Acad. Sci. U. S. A. 100:6358-6363.
24. Chakravarthy, M.V., et al. 2005. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 1:309-322.
25. Pizer, E.S., Wood, F.D., Pasternack, G.R., and Kuhajda, F.P. 1996. Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res. 56:745-751.
26. Postic, C., et al. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274:305-315.
27. Cui, Y., et al. 2004. Essential role of STAT3 in body weight and glucose homeostasis. Mol. Cell. Biol. 24:258-269.
28. Zambrowicz, B.P., et al. 1997. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc. Natl. Acad. Sci. U. S. A. 94:3789-3794.
29. Gannon, M., et al. 2000. Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas. Genesis. 26:139-142.
30. Lee, J.Y., et al. 2006. RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function. J. Biol. Chem. 281:2649-2653.
31. Kim, E.-K., et al. 2002. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. Am. J. Physiol. Endocrinol. Metab. 283:E867-E879.
32. López, M., et al. 2006. Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes. 55:1327-1336.
33. Hu, Z., Cha, S.H., Chohnan, S., and Lane, M.D. 2003. Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proc. Natl. Acad. Sci. U. S. A. 100:12624-12629.
34. Moreno, S., Farioli-Vecchioli, S., and Ceru, M.P. 2004. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience. 123:131-145.
35. Xu, Y., et al. 2006. The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs. Am. J. Physiol. Heart Circ. Physiol. 290:H1798-H1807.
36. Lee, G.Y., Kim, N.H., Zhao, Z.S., Cha, B.S., and Kim, Y.S. 2004. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level. Biochem. J. 378:983-990.
37. Fu, J., et al. 2003. Oleoylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature. 425:90-93.
38. Brun, T., et al. 1996. Evidence for an anaplerotic/malonyl-CoA pathway in pancreatic beta cell nutrient signaling. Diabetes. 45:190-198.
39. Osei-Hyiaman, D., et al. 2005. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest. 115:1298-1305. doi:10.1172/JCI200523057.
40. Obici, S., et al. 2002. Central administration of oleic acid inhibits glucose production and food intake. Diabetes. 51:271-275.
41. Lunzer, M.A., Manning, J.A., and Ockner, R.K. 1977. Inhibition of rat liver acetyl coenzyme A carboxylase by long-chain acyl coenzyme A and fatty acid. J. Biol. Chem. 252:5483-5487.
42. Qian, S., et al. 2002. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol. Cell. Biol. 22:5027-5035.
43. Lee, Y., et al. 2002. PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc. Natl. Acad. Sci. U. S. A. 99:11848-11853.
44. Shimada, M., et al. 1998. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature. 396:670-674.
45. Marsh, D.J., et al. 2002. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc. Natl. Acad. Sci. U. S. A. 99:3240-3245.
46. Momose, K., et al. 1999. Intracerebroventricularly administered corticotrophin-releasing factor inhibits food intake and produces anxiety-like behavior at very low doses in mice. Diabetes Obes. Metab. 1:281-284.
47. Moller, C., Sommer, W., Thorsell, A., Rimondini, R., and Heilig, M. 2002. Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test. Prog. Neuropsychopharmacol. Biol. Psychiatry. 26:119-122.
48. Despres, J.P., Golay, A., and Sjostrom, L. 2005. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med. 353:2121-2134.
49. Wozniak, D.F., et al. 2004. Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults. Neurobiol. Dis. 17:403-414.
50. Tordjman, K., et al. 2001. PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J. Clin. Invest. 107:1025-1034.
51. Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C., and Permutt, M.A. 2001. Islet β cell expression of constitutively active Akt1/PKB induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J. Clin. Invest. 108:1631-1638. doi:10.1172/JCI200113785.
52. Pappan, K.L., et al. 2005. Pancreatic beta-cell lipoprotein lipase independently regulates islet glucose metabolism and normal insulin secretion. J. Biol. Chem. 280:9023-9029.